Takashima M - Search Results

1

[Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer].

Kawaoka T, Takashima M, Yamamoto K, Ueno T, Oka M. Kawaoka T, et al. Among authors: takashima m. Nihon Rinsho. 2006 Jan;64 Suppl 1:279-82. Nihon Rinsho. 2006. PMID: 16457266 Review. Japanese. No abstract available.

2

Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.

Kondo H, Hazama S, Kawaoka T, Yoshino S, Yoshida S, Tokuno K, Takashima M, Ueno T, Hinoda Y, Oka M. Kondo H, et al. Among authors: takashima m. Anticancer Res. 2008 Jan-Feb;28(1B):379-87. Anticancer Res. 2008. PMID: 18383873 Free article. Clinical Trial.

3

Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.

Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S. Kawaoka T, et al. Among authors: takashima m. Oncol Rep. 2008 Jul;20(1):155-63. Oncol Rep. 2008. PMID: 18575732

4

Current antibiotic prophylaxis in pancreatoduodenectomy in Japan.

Ueno T, Yamamoto K, Kawaoka T, Takashima M, Oka M. Ueno T, et al. Among authors: takashima m. J Hepatobiliary Pancreat Surg. 2005;12(4):304-9. doi: 10.1007/s00534-005-0975-2. J Hepatobiliary Pancreat Surg. 2005. PMID: 16133697

5

Improvement of early delayed gastric emptying in patients with Billroth I type of reconstruction after pylorus preserving pancreatoduodenectomy.

Ueno T, Takashima M, Iida M, Yoshida S, Suzuki N, Oka M. Ueno T, et al. Among authors: takashima m. J Hepatobiliary Pancreat Surg. 2009;16(3):300-4. doi: 10.1007/s00534-009-0054-1. Epub 2009 Mar 13. J Hepatobiliary Pancreat Surg. 2009. PMID: 19283336

6

Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.

Wang Y, Kuramitsu Y, Yoshino S, Takashima M, Zhang X, Ueno T, Suzuki N, Oka M, Nakamura K. Wang Y, et al. Among authors: takashima m. Oncol Rep. 2011 Jul;26(1):287-92. doi: 10.3892/or.2011.1278. Epub 2011 Apr 21. Oncol Rep. 2011. PMID: 21519797

7

Protein level of apolipoprotein E increased in human hepatocellular carcinoma.

Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Terai S, Oka M, Nakamura K, Okita K, Sakaida I. Yokoyama Y, et al. Among authors: takashima m. Int J Oncol. 2006 Mar;28(3):625-31. Int J Oncol. 2006. PMID: 16465366

8

Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.

Kuramitsu Y, Harada T, Takashima M, Yokoyama Y, Hidaka I, Iizuka N, Toda T, Fujimoto M, Zhang X, Sakaida I, Okita K, Oka M, Nakamura K. Kuramitsu Y, et al. Among authors: takashima m. Electrophoresis. 2006 Apr;27(8):1651-8. doi: 10.1002/elps.200500718. Electrophoresis. 2006. PMID: 16609938

9

Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma.

Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Harada T, Fujimoto M, Sakaida I, Okita K, Oka M, Nakamura K. Takashima M, et al. Proteomics. 2006 Jul;6(13):3894-900. doi: 10.1002/pmic.200500346. Proteomics. 2006. PMID: 16767786

10

Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.

Tsunedomi R, Iizuka N, Yamada-Okabe H, Tamesa T, Okada T, Sakamoto K, Takashima M, Hamaguchi T, Miyamoto T, Uchimura S, Hamamoto Y, Yamada M, Oka M. Tsunedomi R, et al. Among authors: takashima m. Int J Oncol. 2006 Dec;29(6):1445-51. Int J Oncol. 2006. PMID: 17088983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

559 results

Search Page

Filters